SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 85 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,936,000 | +358.8% | 806,763 | +741.1% | 0.00% | – |
Q3 2018 | $422,000 | -94.1% | 95,916 | -92.3% | 0.00% | -100.0% |
Q2 2018 | $7,149,000 | +54.7% | 1,248,426 | +39.2% | 0.00% | -20.0% |
Q1 2018 | $4,620,000 | +1063.7% | 897,163 | +284.1% | 0.01% | – |
Q3 2017 | $397,000 | +220.2% | 233,563 | +278.2% | 0.00% | – |
Q2 2017 | $124,000 | -57.2% | 61,763 | +14.6% | 0.00% | -100.0% |
Q1 2016 | $290,000 | +14.2% | 53,890 | +84.6% | 0.00% | 0.0% |
Q4 2015 | $254,000 | -75.0% | 29,190 | -49.3% | 0.00% | -50.0% |
Q2 2015 | $1,014,000 | – | 57,547 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
Trexquant Investment LP | 67,929 | $592,000 | 0.05% |